Medical miracle? Experimental drug wipes out colorectal cancer completely in trial
A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...
pharmaphorum1d
GSK rides out vaccine sales weakness with cancer, HIV gains
GSK was able to offset the decline thanks to a better-than-expected performance for its cancer medicines and HIV therapeutics ...
Anaptys to Present at the Guggenheim SMID Cap Biotech Conference
A live webcast of the presentation will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/events. A replay of the webcast will be available for at least 30 days ...
Morningstar3d
Anaptys to Present at the Guggenheim SMID Cap Biotech Conference
Anaptys has also discovered multiple therapeutic antibodies licensed to GSK in a financial collaboration for immuno-oncology, including an anti-PD-1 antagonist (Jemperli (dostarlimab-gxly)) and an ...
Vanda Pharmaceuticals And Anaptys Announce Exclusive Global License Agreement For Vanda To Develop And Commercialize Imsidolimab, An IL-36R Antagonist
Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...
pharmaphorum6d
GSK's Jemperli/TIM-3 immuno-oncology combo moves to ph3
The drugmaker remains convinced of the potential of the drug, however, and has just reported results of a trial comparing Jemperli (dostarlimab) to Merck & Co's market-leading Keytruda ...
Healthline4d
What is ‘Platinum Resistant’ Endometrial Cancer, and How Is It Treated?
Endometrial cancer starts in the tissue that lines your uterus. If the cancer is platinum-resistant, platinum-based chemotherapy drugs will not work well to kill it or stop it from returning after ...